Feasibility and Site Selection
At Confidence Pharmaceutical Research, we understand that every successful clinical trial starts with strategic site selection. We use real-world performance data, therapeutic expertise, and global networks to identify the right sites—faster and smarter. Poor site selection can lead to enrollment delays, protocol deviations, and budget overruns. We approach feasibility as a critical launch point—where smart planning meets real-world execution.
How We Do It?
- Strategic, Data-Backed Feasibility
- Evaluate sites using our proprietary database, including performance history and patient access
- Prioritize capabilities, prior experience, and alignment with protocol requirements
- Global Reach, Local Insight
- Active presence in 35+ countries, with trusted relationships among top-performing investigators
- Country-specific feasibility assessments tied to local regulations and cultural context
- Therapeutic Expertise
- Deep knowledge across oncology, neurology, gastroenterology, dermatology, cardiovascular & coagulation, ophthalmology, infectious disease, orphan/rare diseases, and medical devices
- Feasibility strategies customized per indication and therapeutic complexity
- Collaborative Site Engagement
- Collaborative Site Engagement
- Support in aligning site expectations and optimizing start-up processes
What Sets Us Apart?
- Proprietary, performance-driven site selection tools
- Integrated feasibility and startup acceleration strategy
- Early and continuous Medical (MD/Medical Monitor) involvement from the start of every study
- Established global relationships with investigators and institutions
- Proven results across 35 countries and a wide range of therapeutic areas